Randolph Corteling has been promoted to head of research at ReNeuron Group Plc as the cell therapy company moves further into clinical development. Dr Corteling has been a senior member of the company’s research team since 2007.
Concurrently, Sharon Grimster has been named general manager, Wales in conjunction with the move of the company’s manufacturing operations to South Wales later this year. Meanwhile, Bryan Morton, the ReNeuron chairman since 2011, is stepping down from the board. He has been replaced by John Berriman, a non-executive director of the company since 2011.
ReNeuron announced the appointments on 1 April 2015.
Copyright 2015 Evernow Publishing Ltd